Viewing Study NCT02662712

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 11:08 AM
Ignite Modification Date: 2026-02-24 @ 11:00 AM
Study NCT ID: NCT02662712
Status: COMPLETED
Last Update Posted: 2025-02-03
First Post: 2015-12-02
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of Orally Administered JNJ-56136379 to Evaluate Safety, Tolerability and Pharmacokinetics After Single Ascending Doses and One Multiple Dose Regimen in Healthy Participants (Part I), and After Multiple Dose Regimens in Participants With Chronic Hepatitis B (Part II)
Sponsor: Janssen Sciences Ireland UC
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy View
None Hepatitis, Chronic View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Healthy View
None Hepatitis, Chronic View
None JNJ-56136379 View
None Placebo View